Booth #405
175 Crossing Blvd.
Framingham, MA 01702
Tel: 508-620-9700
Web: www.revobiologics.com
rEVO Biologics, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of specialty therapeutics to address unmet medical needs in patients with rare, life-threatening conditions. The company’s lead product, ATryn, is the first and only plasma-free antithrombin concentrate.